A Study of Lipid Profile in Obese Hypertensive Subjects
DOI:
https://doi.org/10.37506/ijop.v9i4.3086Keywords:
Obesity, Lipid profile,dyslipidaemia, HypertensionAbstract
Background: Obesity is a significant risk factor for metabolic syndrome in adults. Central fat distribution
greatly alters the lipid profile and induces atherogenic dyslipidemia even in normoglycaemic, nonhypertensive
subjects.
Aim and Objectives: Hence, the aim of the present study to assess lipid profile changes in non-obese
hypertensive subjects. Obesity, hypertension and dyslipidemia are the three highly significant risk factor
for the deranged lipid profile. Obesity can be defined as excess accumulation of body fat arising from
a sustained or a periodic positive energy balance that when energy intake exceeds energy expenditure1.
Indicators of overweight are useful in the diagnosis and management of obesity in both children and adults.
Material & Methods: This study was conducted on newly diagnosed cases of essential hypertension
attending medical outdoor of M.G.M. Medical College, Kisangani. A complete clinical examination
including laboratory investigation was done to exclude any systemic or other diseases which are likely to
affect blood lipid levels directly or indirectly.
Results- The association between dyslipidaemia, obesity and hypertension is well establishedand all have
been found to be major risk factor for the development of CAD, a leading cause of visits to physician and
cause of death .
Conclusion: Our study was envisaged to know the effect of obesity on lipid profile profile only in
hypertensive and not in general population, and the study found some definite but paradoxical effects.
These are that in obesity on a background of hypertension, the total and LDL cholesterol as also the HDL
cholesterol are decreased, but on use other hand, the value of VLDL cholesterol and triglycerides are grossly
and significantly increased. These finding have two major Clinical implications in that obese hypertensives
will be more prone to metabolic syndrome and type 2 diabetes mellitus, and steps should be taken to prevent
them accordingly and also apart from statins one should treat the obese hypertensives with fibrates, fat
restriction and physical exercise also.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright Ownership: Authors retain copyright ownership of their work after publication in IJOP. However, they grant the journal an exclusive Creative Commons license.
Creative Commons License: The authors grant IJOP the right to exclusively apply a Creative Commons license to their work upon publication. This license permits use, distribution, and reproduction of the work in any medium, provided that the original work and its source are properly cited. The specific license applied is Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which allows for attribution, non-commercial use, and derivative works.
Editorial Research: Authors grant the journal the right to analyze information obtained from submitted manuscripts for editorial research purposes. This analysis aims to improve the peer-review process, teaching, and training activities.
Warranties: Authors warrant that their work is original, contains no libelous statements, is lawful, and does not infringe upon any copyright, trademark, patent, or proprietary rights of others. Authors agree to indemnify the editors against any costs, expenses, and damages arising from any breach of this warranty.
Views and Opinions: The views and opinions expressed in the article are those of the authors and not necessarily those of the journal.